Twist Bioscience Corp (NASDAQ: TWST) on Monday, plunged -3.37% from the previous trading day, before settling in for the closing price of $46.93. Within the past 52 weeks, TWST’s price has moved between $14.42 and $60.90.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 46.70%. The company achieved an average annual earnings per share of 4.04%. With a float of $56.11 million, this company’s outstanding shares have now reached $57.56 million.
Let’s determine the extent of company efficiency that accounts for 919 employees. In terms of profitability, gross margin is 40.53%, operating margin of -64.35%, and the pretax margin is -74.48%.
Twist Bioscience Corp (TWST) Insider Activity
Observing investor behavior towards Diagnostics & Research industry stocks is more important than anything else. The insider ownership of Twist Bioscience Corp is 4.22%, while institutional ownership is 106.30%. The most recent insider transaction that took place on Oct 09 ’24, was worth 35,791. In this transaction Chief Financial Officer of this company sold 856 shares at a rate of $41.81, taking the stock ownership to the 73,397 shares. Before that another transaction happened on Oct 09 ’24, when Company’s Officer proposed sale 856 for $41.81, making the entire transaction worth $35,791.
Twist Bioscience Corp (TWST) Earnings and Forecasts
As on 6/30/2024, Multinational firm has announced its last quarter scores, in which it reported -0.81 earnings per share (EPS) for the period topping the consensus outlook (set at -0.92) by 0.11. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.64 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 4.04% per share during the next fiscal year.
Twist Bioscience Corp (NASDAQ: TWST) Trading Performance Indicators
Twist Bioscience Corp (TWST) is currently performing well based on its current performance indicators. A quick ratio of 4.52 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 9.00.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.81, a number that is poised to hit -0.70 in the next quarter and is forecasted to reach -2.40 in one year’s time.
Technical Analysis of Twist Bioscience Corp (TWST)
Looking closely at Twist Bioscience Corp (NASDAQ: TWST), its last 5-days average volume was 0.58 million, which is a drop from its year-to-date volume of 0.96 million. As of the previous 9 days, the stock’s Stochastic %D was 79.55%. Additionally, its Average True Range was 2.25.
During the past 100 days, Twist Bioscience Corp’s (TWST) raw stochastic average was set at 35.97%, which indicates a significant decrease from 71.98% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 45.00% in the past 14 days, which was lower than the 66.26% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $44.02, while its 200-day Moving Average is $41.88. However, in the short run, Twist Bioscience Corp’s stock first resistance to watch stands at $46.54. Second resistance stands at $47.74. The third major resistance level sits at $48.91. If the price goes on to break the first support level at $44.17, it is likely to go to the next support level at $43.00. Should the price break the second support level, the third support level stands at $41.80.
Twist Bioscience Corp (NASDAQ: TWST) Key Stats
Market capitalization of the company is 2.66 billion based on 58,226K outstanding shares. Right now, sales total 245,110 K and income totals -204,620 K. The company made 81,460 K in profit during its latest quarter, and -85,570 K in sales during its previous quarter.
